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Friend murine leukemia virus (F-MuLV)  1 induces in certain strains of newborn 
mice an acute erythroleukemia characterized by hepatosplenomegaly and severe 
anemia (1,  2).  Mink cell focus-inducing (MCF) viruses, which are recombinants 
between ecotropic viruses and endogenous envelope sequences present in the 
mouse genome (for review, see reference 3), can be isolated from the spleens of 
these  mice  (4),  and  are  thought  to  play  a  critical  role  in  pathogenicity (5). 
Although strains of mice such as NIH Swiss and BALB/c are very susceptible to 
the development of early erythroleukemia after infection with F-MuLV, most 
other strains of mice, including DBA/2 and C57BL/6, are completely resistant 
(5-7). Resistance appears to be under control of at least one dominant gene, and 
is not correlated with the expression of known resistance genes such as Fv-l, Fv- 
2, or H-2-1inked immune response genes (5,  6).  Although F-MuLV was shown 
to replicate equally well in all strains, MCF viruses were found to replicate only 
in  the  spleens  of mice  from  strains  that  are  susceptible  to  F-MuLV-induced 
disease (5). Injection of pseudotypes of Friend MCF virus into various strains of 
mice results in the development of erythroleukemia only in strains susceptible to 
F-MuLV-induced disease (5).  Thus, the resistance of certain strains of newborn 
mice to F-MuLV-induced disease appears to be due to the failure of MCF viruses 
to replicate and spread in these mice. 
When tissues from various strains of uninfected animals were examined for 
the  endogenous expression  of viral  envelope glycoproteins, it was  found that 
resistant but not susceptible strains of mice endogenously express an MCF virus- 
related envelope glycoprotein that may be responsible for resistance by blocking 
receptors for MCF viruses (5). This hypothesis was strengthened by in vitro data 
indicating that MCF viruses fail to replicate in fibroblasts derived from resistant 
strains of mice, and that this block can be overcome by mechanisms known to 
overcome  viral  interference (8).  Thus,  certain  strains  of mice  appear  to  be 
resistant to F-MuLV-induced erythroleukemia due to the constitutive expression 
of an MCF virus-related envelope glycoprotein that interferes with the replica- 
tion and spread of MCF viruses. Hartley et al. (9) also observed that fibroblasts 
derived from certain strains of mice, including DBA/2, were not able to replicate 
l Abbreviations used in this paper:  F-MuLV,  Friend  murine leukemia  virus; MCF, mink  cell focus- 
inducing; SDS-PAGE, sodium dodecyl  sulfate-polyacrylamide  gel electrophoresis. 
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MCF  viruses,  and  they  mapped  the  responsible  gene,  designated  Rmcff,  to 
chromosome 5. 
Although  DBA/2  and other strains of mice are resistant to the development 
of early erythroleukemia when injected with F-MuLV, they can develop tumors 
(>4 mo after virus infection) that involve not only erythroid cells, but also cells 
of the myeloid and  lymphoid lineages (6,  7,  10,  11).  There is no evidence that 
replication of MCF viruses is necessary for the development of these late diseases. 
To better understand  the genetic basis for the differences in susceptibility of 
mice to F-MuLV-induced early erythroleukemia and the role of MCF viruses in 
this disease, we studied BALB/c and DBA/2 first generation backcross mice, as 
well as a series of BALB/c x  DBA/2 (C X  02) congenic mice. 
Materials and Methods 
Animals  and  Leukemogenicity  Assays.  BALB/c  AnPt  mice  (previously  designated 
BALB/c lr) were originally obtained from H. Andervont, NC1, in  1964. The DBA/2Pt 
mice were derived from DBA/2N mice. The partial C x D~ congenic stocks were originally 
developed to determine whether genetic markers of DBA/2 origin were linked to genes 
that control resistance to plasmacytomas induced by intraperitoneal injection of pristane. 
The methods used in deriving several of the stocks have been previously described: Pep- 
3 b and Idh-lb/Pep-3 b (12); Fv-l", Rmcff/Fv-l"/C, Rmcff, and Qa2 + (13). The Pgm-1 b, Lyt-2  ~, 
C, C/a, C/d, Es-3a/Hba ~, and Igh-1 c stocks were developed by introgressively backcrossing 
the respective DBA/2-derived markers onto BALB/c AnPt.  The phenotypes were de- 
tected by the appropriate enzymatic assays, using starch gel electrophoretic separations, 
or cytotoxic immunoassays. At the designated backcross generation (n), mice were mated 
to each other, and homozygotes for the respective markers were used to found the stock. 
These mice are C x  D2 partial congenic stocks, and are not considered to be true congenic 
mice, because the number of backcrosses is <14. 
All of the mice were bred under conventional conditions at an NCI contract facility 
(contract NO 1-CB-25584 to Litton Bionetics). Mice were infected within 72 h of birth by 
intraperitoneal  injection of 5  x  105  XC-plaque-forming units  of a  stock  of F-MuLV. 
Animals were palpated at intervals, and those judged to have enlarged spleens were killed. 
Data from some of the animals was obtained at autopsy. Mice were considered positive 
for disease if the spleen weight was >0.5 grams and the hematocrit was <30%. 
Viruses and Cells.  The F-MuLV used in this study was the molecularly cloned stock of 
F-MuLV clone 201  that has been previously described (14). Cell-free homogenates (10%) 
of splenic tissue were prepared in Dulbecco-Vogt medium containing 10% fetal calf serum 
and clarified by centrifugation at 2,000 rpm for 10 min. NIH 3T3 cells were then infected 
with various dilutions of each homogenate, and the supernatants of the infected cells were 
monitored for virus production by the reverse transcriptase assay. 
Pulse-labeling,  Immune  Precipitation  and  Polyacrylamide  Gel  Electrophoresis  (PAGE) 
Virus-infected fibroblasts or uninfected bone marrow cells were pulse-labeled with [3~S]- 
methionine as previously described (5,  l 5). Extracts of labeled cells were immune precip- 
itated with either goat anti-Rauscber MuLV gp70 (glycoprotein) serum (obtained from 
the  Division of Cancer  Cause  and  Prevention,  NCI),  goat anti-Moloney MCF  gp70- 
specific serum (15), or normal goat serum. The proteins precipitated were visualized by 
7% sodium dodecyl sulfate (SDS)-PAGE. 
Results 
Occurrence of F-MuLV-induced  Disease in BALB/c Mice Carrying Various DBA/2 
Genes.  BALB/c mice carrying various genes from the resistant  DBA/2  mouse 
were injected as newborns with F-MuLV and observed for the development of 
early erythroleukemia (within  10 wk), as well as late erythroid and nonerythroid RUSCETTI  ET  AL.  1581 
disease  (Table  I).  When  resistant (BALB/c  ×  DBA/2)FI  hybrid mice are back- 
crossed to the susceptible BALB/c strain, 36% of the mice develop early erythroid 
disease.  A  similar incidence  of early erythroleukemia  was noted when resistant 
(NFS ×  DBA/2)F1  hybrid mice were backcrossed to the susceptible NFS mouse. 
These data suggest that more than one gene is involved in resistance of DBA/2 
mice to F-MuLV-induced early erythroid disease. 
To map the resistance genes in the DBA/2 mouse, we used a series of BALB/c 
mice  partially  congenic  for  a  variety  of DBA/2  genes.  As  shown  in  Table  I, 
BALB/c mice congenic for DBA/2 genes on chromosomes  1, 4-7, 9,  12, and 17 
are indistinguishable  from BALB/c mice in their susceptibility to early F-MuLV- 
induced  erythroid  disease.  However,  BALB/c  mice  carrying  the  Rmcf"  gene 
(chromosome 5) of the DBA/2 mouse are extremely resistant to the development 
of early  F-MuLV-induced  erytbroid  disease.  C  x  D2 Pgm-I b mice,  which carry 
another marker on chromosome 5 (Pgm-lb), remain highly susceptible.  BALB/c 
mice carrying chromosome  11  (indicated  by the DBA/2  Es-3 and Hba  loci) or 
chromosome  2  (indicated  by the DBA/2  agouti  locus) also have a  significantly 
reduced  incidence  of early disease.  The  data  also  indicates  that mice carrying 
the Rmcf  ~ gene  are  not  resistant  to  the  development  of late,  multiple-lineage 
tumors induced by F-MuLV. This indicates that other genes control susceptibility 
to these diseases,  as suggested  by earlier studies with DBA/2  and C57BL  mice 
(6, 7,  10,  11). Interestingly, the incidence of late malignancies increases as Rmcf" 
TABLE  I 
F-MuL V-induced Disease in BALB/c Mice Carrying Various DBA/2 Genes 
Strain  N* 
Marker locus  DBA/2  Incidence of disease ~t 
chromosome  4-10 wk  11-16 wk  16-24 wk  Total 
Parental 
BALB/c  90 (19/21)  90 
DBA/2  0 (0/l 9)  16 (3/19)  16 
Backcross 
(BALB/c X DBA/2)F~  x  BALB/c  36 (20/56)  34 (19/56)  9 (5/56)  79 
(NFS x  DBA/2)F~  X NFS  35 (7/20)  40 (8/20)  75 
C x  D2 congenics 
9  Pep-3  b  1  75 (9/12)  25 (3/12)  100 
6  ldh-l~/Pep-3 b  1  85 (11/13)  15 (2/13)  100 
6,  10  Fv-l"  4  70 (21/30)  23 (7/30)  93 
5  Rmcff/Fv-I"/C  5, 4, 7  7 (3/41)  59 (24/41)  7 (3/41)  73 
5  Rmcf"  5  0 (0/101)  7 (7/101)  11 (11/101)  18 
9  Rmcf"  5  0 (0/21)  29 (6/21)  19 (4/21)  48 
6.  10  Pgra-1  b  5  94 (35/36)  97 
5  Lyt-2  °  6  80 (12/14)  86 
10  C  7  77 (30/39)  15 (6/39)  92 
6  C/a  7, 2  27 (4/15)  33 (5/lfi)  60 
4  f;/d  7, 9  86 (12/14)  14 (2/14)  100 
6  Es-3'/Hba a  11  22 (10/46)  35 (16/46)  26 (12/46)  83 
6  Igh-l'  12  60 (9/15)  27 (4/15)  87 
6, 10  Qa2  ~  17  62 (16/26)  38 (10/26)  100 
* N umber of generations backcrossed to BALB/c. 
:~ Animals were palpated at the indicated intervals, and those judged to have enlarged spleens were killed. Data from some animals 
were obtained at autopsy. The disease occurring in mice within 10 wk after virus infection was always an erythroleukemia associated 
with splenomegaly and anemia. The diseases developing later than 10 wk after virus  infection were all associated with splenomegaly, 
but did not exclusively affect the erythroid lineage. Data given as percent, with numbers of diseased mice and numbers of mice in 
test sample in parentheses. 
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congenic mice are backcrossed further to BALB/c (see  N5  vs.  N9),  suggesting 
that  BALB/c genes may favor the development of these late F-MuLV-induced 
diseases. 
Expression of Viral Proteins in C x  D2 Congenic Mice Infected with F-MuL  V.  Since 
the replication of MCF viruses is believed necessary for the development of the 
early erythroleukemia induced by  F-MuLV,  we examined  the  spleens  from  F- 
MuLV-infected mice for replication of both the input F-MuLV and the generated 
MCF virus. This was carried out by preparing cell-free spleen homogenates from 
infected  mice,  passaging  onto  NIH  3T3  fibroblasts,  and  then  examining  the 
fibroblasts for expression of viral proteins by pulse-labeling,  immune precipita- 
tion, and  SDS-PAGE.  As previously shown (5,  15),  the envelope proteins of F- 
MuLV and F-MCF virus can be distinguished by size as well as by precipitation 
with an  MCF  gp70-specific antiserum.  As shown  in  Fig.  1 and summarized  in 
Table  II,  NIH  3T3  cells  infected  with  cell-free spleen  homogenates  from  all 
mice tested  express  high  levels  of the  F-MuLV  envelope precursor,  gPr85 e"v. 
The MCF viral envelope precursor, gPr80  ~nv, was also expressed in cells infected 
with the spleen homogenates from all mice susceptible to early erythroleukemia 
(Fig.  1, A-F, and J) but was not expressed in cells infected with spleen homoge- 
hates  from  Rmcf  mice  (Fig.  1,  G-I),  indicating  that  MCF  viruses  were  not 
replicating in the latter mice. This is consistent with previous data indicating that 
the Rmcp gene restricts the replication of MCF viruses (9). Thus, BALB/c mice 
that  are  congenic  for  the  Rmcf  gene  and  fail  to  replicate  MCF  viruses  are 
resistant to the early erythroleukemia induced by F-MuLV.  Failure to replicate 
MCF  viruses,  however,  is  not the only cause of resistance,  since mice carrying 
FIGURE  1.  Expression of viral proteins in NIH 3T3 cells infected with spleen homogenates 
fi~om F-MuLV-infected C x  D~ congenic mice. Cell-free spleen homogenates were prepared 
from F-MuLV-infected C × D~ congenic mice carrying the following DBA/2 markers: Qa2  ÷ 
(a ), Fv-l" (B), Idh-lb/Pep-3  ° (C), C/d (D), C/a (E), Es-3C/Hba  ~  (F), Rmcff N5 (G), Rmcp N9 (H), 
Rmcf/Fv-t"/C (/), and Pgm-1  ~  (J). The homogenates were passaged onto NIH 3T3 cells, the 
cells were labeled  35  with [  Slmethionine, and the labeled extracts were precipitated with goat 
anti-Rauscher  MuLV gp70 serum (lanes 1), or normal goat serum (lanes 2).  Precipitated 
proteins were then visualized  by 7% SDS-PAGE  and autoradiography. RUSCETTI  ET  AL. 
TABLE  II 
Infectious MuL V in Cell-free Spleen Homogenates From F-MuL  V-infected Mice 
1583 
Viral proteins 
expressed in NIH 
3T3  cells infected 
DBA/2  Early  with spleen 
Strain  Marker locus  chromosome  erythroleu-  homogenates from 
kemia  infected mice* 
F-MuLV  MCF 




c  x  D~ congenics 
+  +  + 
Pep-3  b  1  +  +  + 
ldh-lb/Pep-3  b  1  +  +  + 
Fv-1 "/"  4  +  +  + 
Rmcf'/Fv-1"/C  5, 4, 7  -  +  >  - 
Rmcp (N5)  5  -  +  - 
Rmcff (N9)  5  -  +  - 
Rmcp (N5)  5  -  +  - 
Pgm-1 n  5  +  +  + 
Lyt-2"  6  +  +  + 
C  7  +  +  + 
C/a  7, 2  +/-  +  + 
C/d  7, 9  +  +  + 
Es-3C/Hba"  1 1  +/-  +  + 
Igh-1 c  12  +  +  + 
Qa2  +  17  +  +  + 
*  Cell-free spleen homogenates from diseased mice were passaged onto NIH  3T3  cells, and protein 
expression  was determined by pulse-labeling, immune precipitation, and SDS-PAGE, as previously 
described (15). 
the DBA/2 Es-3/Hba (Fig.  1 F) and C/a (E) loci have no defect in their ability to 
replicate  F-MuLV  or  MCF  viruses,  yet  they have a  considerably  reduced  inci- 
dence of early erythroleukemia.  Thus,  other  DBA/2  genes in these mice  must 
be controlling the development of erythroleukemia by a different mechanism. 
Analysis of CeUs  from Uninfected Mice for Viral Protein Expression.  Normal cells 
from DBA/2 mice have previously been shown to constitutively express an MCF 
virus-related envelope glycoprotein that cannot be detected in cells from suscep- 
tible strains such as BALB/c  (5). This protein is thought to bind to the receptor 
for MCF viruses and block incoming MCF viruses from infecting the cell (8). To 
determine  whether  C  X  O2  congenic  mice  carrying the Rmcf  ~ gene also consti- 
tutively  express  an  MCF-related  envelope  protein,  bone  marrow  cells  from 
uninfected mice were examined.  As shown in Fig. 2, bone marrow cells from C 
X  02 mice carrying the Rmcf  ~ gene express an 80 kilodaiton (kD) protein that is 
precipitable  with  an  MCF  gp70-specific  antiserum  (Fig.  2A).  No such protein 
could be detected  in cells from other congenic mice examined (Fig. 2, B-D), all 
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FIGURE 2.  Expression of envelope proteins in bone marrow cells from  uninfected C  ×  D~ 
congenic  mice.  Bone  marrow  cells  were  removed  from  the  femurs  of uninfected  C  x  D~ 
congenic mice carrying the following DBA/2 markers: Rmcf" (A), Pgm-1 b (B), C/a (C), and Es- 
3/Hba  ~ (D). The cells were labeled for 2 h with [3~S]methionine, and the labeled extracts were 
immune precipitated  with an  MCF  gp70-specific  goat  antiserum (lanes  1)  or  normal  goat 
serum (lanes 2). Precipitated proteins were visualized by 7% SDS-PAGE and autoradiography. 
Discussion 
The studies  reported  here  establish  that  DBA/2  mice carry a  gene on chro- 
mosome 5 at or near the Rmcflocus that plays a major role in resistance to early 
F-MuLV-induced erythroleukemia.  The fact that this gene controls the replica- 
tion  of MCF viruses (9) strengthens  the case for these viruses playing a  crucial 
role in the disease, since failure to replicate these viruses results in resistance to 
early erythroleukemia (5 and this study). The data also indicate that additional 
genes on other chromosomes may contribute to resistance  to F-MuLV-induced 
early erythroleukemia, although their mechanisms are unknown. 
Normal cells from DBA/2 mice have previously been shown (5) to constitutively 
express an MCF-related envelope glycoprotein on the cell surface that cannot be 
detected on  the surface of cells from susceptible strains  such as BALB/c.  This 
protein apparently binds to the receptor for MCF viruses and blocks incoming 
MCF viruses from infecting  the cell (8).  Cells from BALB/c mice congenic for 
the Rmcff gene also express an MCF-related envelope glycoprotein, which is most 
likely responsible  for the  failure  of MCF viruses to replicate  in  this  strain.  No 
such protein could be detected on the surface of cells from the other congenic 
mice studied, all of which replicate MCF viruses well. Thus, the Rmcf  ~  gene may 
represent a unique viral envelope gene, or may be a regulatory locus that governs 
the expression of this envelope gene. It is not known whether the BALB/c mouse 
completely lacks the Rmcfgene or carries a  different allele of this gene (RmcJ  ~) 
that is not expressed. 
There  are  other  examples of resistance  to retrovirus-induced  diseases being 
associated with expression  of endogenous envelope genes.  In the mouse, repli- 
cation  of ecotropic virus  is blocked in  mice  carrying  the Fv-4  r allele,  which  is 
associated with  the constitutive expression  of an  ecotropic viral  envelope gene 
whose product  blocks the replication  of ecotropic viruses by viral  interference RUSCETTI  ET  AL.  1585 
(16-18).  Also,  chickens  expressing  defective,  endogenous  avian  leukosis  viral 
subgroup E envelope genes were shown to be resistant to infection with subgroup 
E viruses (19). 
While  it  is  clear  that  the  Rmcf  gene  plays  a  major  role  in  resistance  of 
DBA/2 mice to early F-MuLV-induced erythroleukemia, the basis for resistance 
in C57BL mice is unclear, and may be under control of yet another  resistance 
gene  (10,  11).  These  mice do not carry  the  Rmcf  ~ gene  (9),  yet MCF  viruses 
cannot be detected after infection with F-MuLV. Endogenous MCF virus-related 
envelope glycoproteins can be detected in  cells derived from C57BL mice (5), 
but they are apparently not the same as the protein expressed in Rmcf" mice that 
blocks the receptor for MCF viruses. Perhaps C57BL mice carry a genetic defect 
that prevents the generation of MCF viruses or affects the number of target cells 
available for MCF virus infection. 
Since  the  Rmcf  ~ gene  controls  the  replication  of MCF  viruses,  its  presence 
should be associated with resistance to all leukemias that are mediated by MCF 
viruses.  The  incidence  of spontaneous  and  MCF  virus-induced  lymphomas  in 
AKR mice was shown (20, 21) to be greatly reduced when the mice were crossed 
to DBA/2, which carries the Rmcf  ~  gene. On the other hand, the Rmcf  ~  gene had 
no effect on the incidence of pristane-induced  plasmacytomas in BALB/c mice 
(13), indicating that MCF viruses play no role in this disease. 
Future studies on the Rmcf  ~ gene will focus on cloning the gene to determine 
whether it represents a structural  gene for a  unique envelope glycoprotein or a 
regulatory gene that controls expression of this envelope gene. 
Summary 
Using a  series of BALB/c mice congenic for various DBA/2 genes, we were 
able to establish that DBA/2 mice carry a gene on chromosome 5, at or near the 
Rmcf  ~  locus, that plays a major role in resistance to early erythroleukemia induced 
by injection of Friend murine leukemia virus (F-MuLV) into newborn mice. The 
fact that  this  gene  controls the  replication  of mink  cell  focus-inducing (MCF) 
viruses  strengthens  the  case  for  these  viruses  playing  a  crucial  role  in  the 
development of erythroleukemia,  since failure to replicate  MCF viruses results 
in  resistance  to  early  erythroleukemia.  The  expression  of the  Rmcp  gene  is 
correlated  with  the  constitutive  expression  of an  MCF virus-related  envelope 
glycoprotein  that  apparently  blocks the  receptor  for  MCF  viruses,  preventing 
their  spread.  Thus,  the Rmcf gene  is either  a  structural  gene  for this  unique 
protein,  which can block the receptor for MCF viruses, or is a regulatory gene 
that controls expression of such a  structural  gene.  Although  the Rmcf gene is 
clearly involved in resistance to the early erythroleukemia induced by F-MuLV, 
it appears to have no effect on the late myeloid, lymphoid or erythroid diseases 
that  appear  in  DBA/2  and  other  strains  of mice  after  injection  of F-MuLV, 
consistent with  data indicating  that  replication  of MCF viruses is not required 
for  the  development  of  these  late  diseases.  Our  studies  with  congenic  and 
backcross mice also indicate that,  in addition  to the Rmcf" gene, other genes of 
DBA/2 origin may contribute to resistance to F-MuLV-induced early erythroleu- 
kemia by mechanisms other than blocking the replication of MCF viruses. 1586  DBA/2  GENES AND  SUSCEPTIBILITY  TO  ERYTHROLEUKEMIA 
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